BRPI0603027A - compostos de 1,1-piridilaminociclopropanamina polissubstituìdos, um processo para preparação deles e composições farmacêuticas contendo os mesmos - Google Patents

compostos de 1,1-piridilaminociclopropanamina polissubstituìdos, um processo para preparação deles e composições farmacêuticas contendo os mesmos

Info

Publication number
BRPI0603027A
BRPI0603027A BRPI0603027-0A BRPI0603027A BRPI0603027A BR PI0603027 A BRPI0603027 A BR PI0603027A BR PI0603027 A BRPI0603027 A BR PI0603027A BR PI0603027 A BRPI0603027 A BR PI0603027A
Authority
BR
Brazil
Prior art keywords
compounds
pyridylaminocyclopropanamine
polysubstituted
group
hydrogen atom
Prior art date
Application number
BRPI0603027-0A
Other languages
English (en)
Inventor
Solo Goldstein
Claude Guillonneau
Yves Charton
Brian Lockhart
Pierre Lestage
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of BRPI0603027A publication Critical patent/BRPI0603027A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

"COMPOSTOS DE 1,1-PIRIDILAMINOCICLOPROPANAMINA POLISSUBSTITUìDOS, UM PROCESSO PARA PREPARAçãO DELES E COMPOSIçõES FARMACêUTICAS CONTENDO OS MESMOS". A presente invenção refere-se a compostos de fórmula (I): em que: n representa um número inteiro de 1 a 6, inclusive; R~ 1~ e R~ 2~ representam um átomo de hidrogênio, um grupo (C~ 1~ - C~ 6~) ou um grupo aril - (C~ 1~ - C~ 6~) alquila; R~ 3~ e R~ 4~ representam um átomo de hidrogênio ou um grupo (C~ 1~ - C~ 6~) alquila; R~ 5~ e R~ 6~ representam um átomo de hidrogênio ou um grupo (C~ 1~ - C~ 6~) alquila, halogênio, hidróxi, grupo (C~ 1~ - C~ 6~) alcóxi, ciano, nitro, grupo (C~ 2~ - C~ 6~) acila, (C~ 1~ - C~ 6~) alcoxicarbonila, (C~ 1~ - C~ 6~) trihaloalquila, ou (C~ 1~ - C~ 6~) trihaloalcóxi ou um grupo amino opcionalmente substituído; e R~ 7~ representa um átomo de hidrogênio, um grupo (C~ 1~ - C~ 6~) alquila ou um grupo arilalquila.
BRPI0603027-0A 2005-07-28 2006-07-28 compostos de 1,1-piridilaminociclopropanamina polissubstituìdos, um processo para preparação deles e composições farmacêuticas contendo os mesmos BRPI0603027A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0508032A FR2889188B1 (fr) 2005-07-28 2005-07-28 Nouveaux composes 1,1-pyridinylaminocyclopropanamines polysubstitues, leur procede de preparation et les compositions phamaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
BRPI0603027A true BRPI0603027A (pt) 2007-03-13

Family

ID=36169157

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0603027-0A BRPI0603027A (pt) 2005-07-28 2006-07-28 compostos de 1,1-piridilaminociclopropanamina polissubstituìdos, um processo para preparação deles e composições farmacêuticas contendo os mesmos

Country Status (32)

Country Link
US (2) US7388022B2 (pt)
EP (1) EP1757586B1 (pt)
JP (1) JP2007031439A (pt)
KR (1) KR100824831B1 (pt)
CN (1) CN100448848C (pt)
AR (1) AR055589A1 (pt)
AT (1) ATE416166T1 (pt)
AU (1) AU2006203237A1 (pt)
BR (1) BRPI0603027A (pt)
CA (1) CA2552831A1 (pt)
CR (1) CR9679A (pt)
DE (1) DE602006003956D1 (pt)
DK (1) DK1757586T3 (pt)
EA (1) EA011124B1 (pt)
EC (1) ECSP088127A (pt)
ES (1) ES2318700T3 (pt)
FR (1) FR2889188B1 (pt)
GE (1) GEP20084506B (pt)
GT (1) GT200800005A (pt)
HK (1) HK1098146A1 (pt)
HR (1) HRP20090090T3 (pt)
MA (1) MA28425B1 (pt)
MX (1) MXPA06008541A (pt)
NO (1) NO20063462L (pt)
NZ (1) NZ548746A (pt)
PL (1) PL1757586T3 (pt)
PT (1) PT1757586E (pt)
SG (1) SG129412A1 (pt)
SI (1) SI1757586T1 (pt)
TN (1) TNSN08023A1 (pt)
WO (1) WO2007012761A1 (pt)
ZA (1) ZA200606276B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2896800B1 (fr) * 2006-01-30 2008-04-11 Servier Lab Nouveaux composes pyridinylaminoalkylene-et pyridinyloxyalkylene-cyclopropanamines polysubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US10288289B2 (en) * 2014-12-12 2019-05-14 United Technologies Corporation Gas turbine engine diffuser-combustor assembly inner casing

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2095350C1 (ru) * 1993-10-13 1997-11-10 Центр по химии лекарственных средств (ЦХЛС-ВНИХФИ) 3-(n,n-диметилкарбамоилокси)-2-этил-6-метилпиридина сукцинат, обладающий антигипоксической активностью
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
BR9813279B1 (pt) * 1997-10-27 2010-11-16 derivado de homopiperazina, composição farmacêutica, e, uso do derivado de homopiperazina.
CA2376061A1 (en) * 1999-06-07 2000-12-14 Targacept, Inc. Pharmaceutical compositions and methods for use
JP2001261652A (ja) * 2000-03-21 2001-09-26 Suntory Ltd 二置換イミノヘテロサイクリック化合物
US6448276B1 (en) * 2000-05-17 2002-09-10 Inspire Pharmaceuticals, Inc. Method for treating vaginal dryness with nicotinic acetylcholine receptor agonists
FR2810664B1 (fr) * 2000-06-27 2004-12-24 Adir Nouveaux composes cyclopropaniques 1,1 et 1,2-dissubstitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
AR055589A1 (es) 2007-08-29
ATE416166T1 (de) 2008-12-15
PL1757586T3 (pl) 2009-04-30
NZ548746A (en) 2007-06-29
CN100448848C (zh) 2009-01-07
US7388022B2 (en) 2008-06-17
FR2889188A1 (fr) 2007-02-02
CR9679A (es) 2008-02-20
US20080146621A1 (en) 2008-06-19
HK1098146A1 (en) 2007-07-13
KR20070015012A (ko) 2007-02-01
ECSP088127A (es) 2008-02-20
EP1757586A1 (fr) 2007-02-28
EA200601247A1 (ru) 2007-04-27
WO2007012761A1 (fr) 2007-02-01
GT200800005A (es) 2008-09-24
CN1903844A (zh) 2007-01-31
FR2889188B1 (fr) 2007-09-07
AU2006203237A1 (en) 2007-02-15
GEP20084506B (en) 2008-10-10
PT1757586E (pt) 2009-02-17
CA2552831A1 (fr) 2007-01-28
WO2007012761A8 (fr) 2007-12-21
NO20063462L (no) 2007-01-29
SG129412A1 (en) 2007-02-26
DK1757586T3 (da) 2009-03-09
DE602006003956D1 (en) 2009-01-15
KR100824831B1 (ko) 2008-04-23
MXPA06008541A (es) 2007-01-29
HRP20090090T3 (en) 2009-03-31
ES2318700T3 (es) 2009-05-01
EP1757586B1 (fr) 2008-12-03
JP2007031439A (ja) 2007-02-08
US20070027192A1 (en) 2007-02-01
SI1757586T1 (sl) 2009-04-30
MA28425B1 (fr) 2007-02-01
ZA200606276B (en) 2007-12-27
EA011124B1 (ru) 2008-12-30
TNSN08023A1 (en) 2009-07-14

Similar Documents

Publication Publication Date Title
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
UY29360A1 (es) Nuevos derivados de pirazol, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones.
BRPI0900983A2 (pt) compostos de diometina, processo para sua preparação e composições farmacêuticas contendo os mesmos
CY1115893T1 (el) Anti-μολυσματικες πυριμιδινες και χρησεις αυτων
BRPI0507903A (pt) derivados de quinazolina e composição farmacêutica compreendendo os mesmos
EA200970156A1 (ru) Пиридизиноновые производные
BRPI0513858A (pt) compostos de benziltriazolona como inibidores não-nucleosìdeos da transcriptase reversa
TW200722086A (en) Compounds comprising an oxazole or thiazole moiety, processes for making them and their uses
BRPI0411268C1 (pt) processo para a preparação de compostos 3-aril butil-amina substituído
BRPI0508102A (pt) inibidores de caspase e usos dos mesmos
EA201101334A1 (ru) Новые соединения бензотиадиазепина, способ их приготовления и фармацевтические композиции, содержащие их
BRPI0607797A2 (pt) processos para a fabricação do composto, e para a desproteção de um composto, e, composto
BR112013018732A2 (pt) novos derivados de amida de aril-benzocicloalquila
NO20081685L (no) Fremgangsmate for fremstilling oksazolidin-beskyttelse aminodolforbindelser anvendbare som mellomprodukter for Florfenicol
PE20081533A1 (es) Azolilmetiloxiranos, su uso para combatir hongos fitopatogenos, asi como productos que contienen los mismos
EA201000814A1 (ru) 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств
CY1116875T1 (el) Διϋδροετορφινες και η παρασκευη αυτων
BRPI0517390A (pt) processo para a preparação de derivados de [1,4,5]-oxadiazepina
AR047810A1 (es) Proceso quimico
BRPI0507979A (pt) processo para preparação de um composto
DE60312029D1 (de) Verfahren zur herstellung c-7 substituierter 5-androstene
BRPI0516994A (pt) processo para preparação de pirazóis
ECSP088360A (es) Métodos para preparar derivados de ácido glutámico

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 5A E 6A ANUIDADES.